Vaccines

Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations

3 monthes ago   |   By Xconomy

Merck exited the holiday weekend with some fireworks of its own, announcing three major programs on Tuesday all related to investments in finding ways to treat and prevent COVID-19. The Kenilworth, NJ-based pharma giant said it had inked an agreement to acquire Austrian vaccine developer Themis, which has a COVID-19 candidate in preclinical development; develop another investigational vaccine with nonprofit IAVI, which also has a candidate in preclinical development; and develop and commercialize a clinical-stage antiviral candidate being advanced by Florida biotech Ridgeback...
Read more ...

 


Search by Tags

   Vaccines      Pharma      Biotech      BioTech      Clinical      Vaccine      National blog main      New York      New York blog main      New York top stories      Collaboration      Coronavirus      COVID-19      Deals      Licensing      Life Sciences      M&A      Merck      Ridgeback Bio      Roger Perlmutter      Themis  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Berkeley Team Plays Key Role in Analysis of Particle Interactions That...

Berkeley Team Plays Key Role in Analysis of Particle Interactions That Produce Matter From Light

This image shows a reconstruction of a particle event at CERN's ATLAS detector that produced W bosons from photons, which are particles of light. Researchers at the U.S... Read more ...

Tau-Targeting Alzheimer's Drug from AC Immune, Roche Fails in Phase 2

Tau-Targeting Alzheimer's Drug from AC Immune, Roche Fails in Phase 2

An Alzheimer's disease drug from partners AC Immune and Roche has failed a mid-stage clinical trial, adding another compound to the list of experimental therapies that have... Read more ...

Athira CEO Kawas: Alzheimer's Drug Aims for “Recovery of Brain Function”

Athira CEO Kawas: Alzheimer's Drug Aims for “Recovery of Brain Function”

The key to Athira Pharma's approach to Alzheimer's disease is already inside each of us: a repair mechanism that can regenerate damaged neurons. What's needed to begin the... Read more ...

Gene Therapy Firms Seek Clarity on FDA Exclusivity, Orphan Designations

Gene Therapy Firms Seek Clarity on FDA Exclusivity, Orphan Designations

Gene therapy product developers are seeking more clarity from the US Food and Drug Administration on when viral vectors from the same class will be considered sufficiently... Read more ...

Checkmate, Chromosome 8: The First End-to-End Sequence of a Human Autosome

Checkmate, Chromosome 8: The First End-to-End Sequence of a Human Autosome

Even in the field of genomics where new breakthroughs occur every few months, completion of the first-ever fully sequenced human autosome is a momentous achievement. Highly... Read more ...

Animal Technician

Our client, a leader in scientific research, is seeking an animal technician. JOB SUMMARY This entry level position is responsible for the daily care of research animals... Read more ...

Scientist I - Janux Therapeutics, Inc. - San Diego, CA

Success in this role requires high attention to detail with the ability to multi-task. The individual will provide technical and scientific expertise in efforts... $56,000... Read more ...

Likely molecular mechanisms of SARS-CoV-2 pathogenesis are revealed by...

Researchers have built an interactome that includes the lung-epithelial cell host interactome integrated with a SARS-CoV-2 interactome. Applying network biology analysis tools... Read more ...

Structural biology: Ribosomes and Russian dolls

Maturation of the ribosome is a complex operation. Work now shows that the 90S precursor of the small 40S subunit undergoes a 'molting' process, during which it progressively... Read more ...

Knockoff Boosted Tree for Model-Free Variable Selection

AbstractMotivationThe recently proposed knockoff filter is a general framework for controlling the false discovery rate when performing variable selection. This powerful new... Read more ...